Gut biome analysis: a snapshot of the microbes in your gut

How Gut Biome Analysis works

You collect a small stool sample at home using the kit and mail it to the lab. The lab extracts bacterial DNA and sequences it to identify which groups of bacteria are present and in what relative amounts. The report typically includes a diversity measure and inferred functions, such as the potential to make short-chain fatty acids.

Who it’s for, and who it isn’t

What’s included

• At-home stool collection kit with return packaging
• Analysis by a CLIA-certified laboratory
• Clinician review of your report alongside your history and labs
• Online visit to discuss practical next steps
• No membership fee

Possible side effects

• No physical side effects; collection is non-invasive
• Results can be hard to interpret and may prompt unnecessary diet restriction or supplement buying
• Recent antibiotics, illness or travel can skew a single snapshot

This isn’t a complete list. Your clinician reviews risks, interactions and warnings with you before prescribing. In an emergency, call 911.

What the evidence says

The gut microbiome is an active research field with strong links to health in population studies. But an international expert consensus published in The Lancet Gastroenterology and Hepatology in 2025 concluded that evidence supporting the clinical usefulness of microbiome testing is scarce, and warned that direct-to-consumer tests lack regulatory consensus and proven value.

What the test measures

Your gut contains trillions of microbes. This test reads the bacterial DNA in a stool sample to estimate which groups are present and how they compare with each other. Reports often include a diversity score and estimates of what those bacteria may be capable of producing.

It does not measure how well you digest food, whether your gut is inflamed or whether you absorb nutrients well. Those questions need different tests.

What experts say about microbiome testing

In 2025, an international panel of microbiome researchers and gastroenterologists published a consensus statement on microbiome testing in clinical practice. They concluded that evidence supporting its clinical usefulness is scarce, and that commercial tests are offered without agreed standards or proven value.

That does not make the test useless. It means results are best read as context rather than instructions, by a clinician who can keep you from over-interpreting them.

Making sense of a diversity score

Many reports lead with a single diversity number. In research, greater diversity of gut bacteria has often been associated with better health, and lower diversity with some chronic conditions. But these are associations seen across groups of people, and there is no agreed healthy range for an individual.

A lower score than average is not a diagnosis, and a higher one is not a clean bill of health. Different labs use different methods, so scores are not comparable from one company to another. Your clinician looks at the overall pattern alongside your diet, medicines and symptoms rather than chasing one number.

Who it may suit, and who it doesn't

The test fits people without worrying gut symptoms who want a baseline, perhaps before a sustained change toward more fiber and plant variety, or alongside metabolic or weight goals.

It is not the right first step if you have symptoms. The National Institute of Diabetes and Digestive and Kidney Diseases lists anemia, rectal bleeding, bloody or black stools and weight loss as signs that need further evaluation, which may include a colonoscopy. If you have persistent bloating, pain or bowel changes, the GI Effects + Microbiomix panel or an in-person work-up may be more appropriate.

It is not a cancer screen

A microbiome report cannot detect colorectal cancer or polyps. The National Cancer Institute notes that most expert groups recommend average-risk adults begin colorectal cancer screening at 45, using options such as colonoscopy or stool-based tests like FIT.

If you are 45 or older and not up to date on screening, your clinician will encourage you to arrange it with your primary care doctor or a gastroenterologist.

Midlife changes that affect the gut

Many things that shift in your 40s and 50s can affect digestion and gut bacteria: changes in estrogen and progesterone around menopause, new medicines such as GLP-1s, acid reducers or antibiotics, less physical activity, and changes in sleep and stress. Some people notice more bloating or constipation during these years.

A microbiome snapshot can sit alongside these conversations, but it rarely explains symptoms on its own. Your clinician will ask about these factors first, because they are often easier to act on than a list of bacterial names.

Collecting your sample

Collection takes a few minutes at home with the supplies in the kit. Your instructions will explain how to time it around antibiotics, probiotics and other medicines, since recent antibiotics in particular can change results for weeks.

Because the microbiome shifts with diet, travel, illness and medication, a single result is a snapshot. If you retest later, try to collect under similar conditions.

After your results

Your clinician reviews the report with you and focuses on practical, low-risk steps, such as building fiber gradually or broadening the variety of plants you eat. You will not be handed a long list of supplements to buy.

Gut Biome Analysis is a laboratory-developed test run by a CLIA-certified lab; it has not been cleared or approved by the FDA. The price is $625, one-time, confirmed during your eligibility review. There is no membership fee.

Go deeper on Gut Biome Analysis